Engineered measles virus as a novel oncolytic therapy against prostate cancer. - Wikidata - awgldk - TriplyDB

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

http://www.wikidata.org/entity/Q37332702

about

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy Measles to the Rescue: A Review of Oncolytic Measles Virus Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.Viral oncolysis - can insights from measles be transferred to canine distemper virus?Antibody neutralization of retargeted measles viruses.Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.Different roles of the three loops forming the adhesive interface of nectin-4 in measles virus binding and cell entry, nectin-4 homodimerization, and heterodimerization with nectin-1 Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus.Attenuated oncolytic measles virus strains as cancer therapeutics Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain.Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors Oncolytic measles virus strains as novel anticancer agents.Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy.Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.Use of attenuated paramyxoviruses for cancer therapy.Potential and clinical translation of oncolytic measles viruses.Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma.Novel oncolytic viral therapies in patients with thoracic malignancies.Oncolytic Alphaviruses in Cancer Immunotherapy.Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.Oncolytic measles virus retargeting by ligand display Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights.Theranostic potential of oncolytic vaccinia virus.Viral mutagenesis as a means for generating novel proteins.Virosome presents multimodel cancer therapy without viral replication.Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.Future prospects in the diagnosis and management of localized prostate cancer.

P2860

Q24605512-C85AE76F-3821-4008-878A-82A5170756FC Q28072097-1E54A406-B253-46AC-964C-612250F7BECC Q28817152-E3F79AEC-9676-4BB9-A58E-6F5BE4B79295 Q30496489-4F0003D9-A5BA-4C2B-9CC5-7ABAD7D99276 Q30502129-54B6F83E-06A0-4B46-97BA-DCC9505F3766 Q33605148-6EBD9DF6-0A79-4AC6-AEC1-ECDAA8663BFA Q33820717-C2FFAD6C-3E9D-401F-B9F7-9CD55F04E091 Q34010344-0C852830-8917-4985-A4B1-D63AEED21C3F Q34292273-E6C82604-A5C2-48E4-A621-9C847A7E790A Q34382986-6EBC4A2F-4B08-4781-9854-901886B8540C Q34478419-040277A4-4B96-4153-9A44-EB1069C58BB0 Q34542092-EDABDF00-70E3-4556-8345-3DB8CD43A3C7 Q34594866-3A379B10-48BA-41CC-B2C8-098A64F37E5B Q35785494-0F36D0E5-B885-462A-A1F1-A4D306C1429E Q35818876-E3E070AF-AE87-4680-9AB1-580D5F759F38 Q36014057-822F556D-253E-4CB4-833A-1F39F3864FC3 Q36140704-B3DD6BEF-0DA4-4586-B81F-1A10BF1F0312 Q36250723-EB1F8396-5476-433E-8B46-7665AA337885 Q37261017-7F342539-6A8F-4502-969A-5F6764B266DE Q37280354-420317C7-9A96-4FCD-9BE0-D1A8C15B7F50 Q37520335-579EA487-A34E-4246-8082-BE6AF5B9013B Q37557813-6CA0D362-DB8C-4E81-978F-CB046EF5B5F0 Q37690397-90C00701-B10C-4294-8B23-C535DAC803D2 Q37810599-19CBE18C-02AF-477A-BFE2-6CB0D4D6A5B8 Q38764947-BB48068C-0CF7-43E7-9A85-5233D657D72F Q38940653-0386574F-D2C4-419E-9F03-825D42145388 Q39067827-B26E670B-85F5-403E-85C8-32F19AE5526D Q39247874-8B7E54E3-15AC-4ADD-8A8E-194B7E90482C Q39327842-2D82E42B-5721-4094-9CF9-8CFA1BA73883 Q39444656-5A8EDE9B-741A-4F66-815B-320263A64EF9 Q39467892-F17EE45F-B0BD-4AED-B6F9-101FCCD627A9 Q39467959-BFBF0EFA-CFA0-4D8A-A27D-EC2F0E1A6AC6 Q39572142-C6CAD890-8F6D-4B86-A5CF-D7CADD1CD3B7 Q39628429-D3FCB293-2083-4C66-8DAD-D63F95EAD758 Q39776023-EC047386-A359-4DCC-9DAF-8737CAC9204F Q41812409-4338A2ED-E5FC-4A30-B47F-A3F315FE85D9 Q41869447-52D04AF3-46B2-40EB-8FE8-74D5808DD45B Q42572418-4C34B4BB-11F6-4062-8369-D6B3AB48F9DB Q50056861-BD547914-5E8A-4771-A61A-B6F830C4AF2D Q51348320-1C31708E-E635-4DCA-AAFC-0BE7F1BDCF9B

P2860

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

http://www.wikidata.org/entity/Q37332702

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en-gb

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@nl

type

label

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en-gb

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@nl

prefLabel

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en-gb

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@nl

P1433

Q37332702-12D49771-9DDF-42C0-BA58-97C61702949F

P1476

Q37332702-FBD6DD8E-40D8-458B-B29B-F3E5EC771D88

P2093

Q37332702-03899ED5-BE5D-41FB-BE35-724207626A4C

Q37332702-29E0D689-EDF7-4426-A451-ECB896D6C6E6

Q37332702-4A9A1FC3-BFD2-40B0-8016-3DDC208A1E5C

Q37332702-54EC631D-3D90-426A-B79F-595EE03086BE

Q37332702-75AC914C-A50F-4104-AE5A-44E6866CD363

Q37332702-9F2E4390-0E77-4667-A039-9639FE17BCDD

P2860

Q37332702-05BC213F-D873-4569-A8C0-67D85E4D3319

Q37332702-0A4E8233-0F49-40D2-9923-4D5782A6B3C3

Q37332702-0D6A3A41-E16F-491F-892C-98274B6A9A5C

Q37332702-17AF63FF-3F1A-423F-900A-A62FDFC70F5C

Q37332702-18548CE8-48F2-45F1-9295-A7E3737E51CF

Q37332702-19C90F93-7B0A-435F-99F8-127819C6F6FC

Q37332702-1A33F102-A4F3-49B8-8CC7-3B70185CBDBF

Q37332702-1D564BC7-997A-4DAA-BF5E-2195DF4A66C9

Q37332702-22FF94D6-71FE-4B55-9E4A-89F85F7CB238

Q37332702-30A8660F-823E-491A-8B39-C020380F60C9

P304

Q37332702-0BAA8A5C-0E0A-417F-85FF-8A5AD238673D

P31

Q37332702-0D5F944F-8634-497A-9DCA-015CD6C029A6

P356

Q37332702-D739F7F3-92A9-4BB7-BBB2-F62FB6B8A6C4

P433

Q37332702-5D0FD5F7-6995-4BB9-AE94-1943845791C3

P478

Q37332702-47D9B1C3-FA20-4DEE-9FB7-3BDAD018B576

P50

Q37332702-259250F1-99D1-4ADD-940F-3A5323498027

Q37332702-262B762E-C08C-4239-9A0A-9F1D8921F5CA

Q37332702-38056CA0-ADDA-4C3F-9ED9-DDBA6F9A2E82

P577

Q37332702-8D0C684D-40F1-4E93-8256-FCDFC83156E7

P5875

Q37332702-8F0B7D00-8026-4EA5-A1BA-5B48D3B1F456

P698

Q37332702-0D8EA711-9464-4F39-9631-D5BA5011C3A8

P921

Q37332702-10B662A6-BF37-4512-8328-34666695AE6D

Q37332702-4E9DD455-9329-48F8-ADE9-A9A70231A268

P932

Q37332702-5FCE4C28-DE32-47A6-9A90-CB9FA9FF549B

P356

P1433

P1476

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

@en

P2093

Cory Allen

http://www.w3.org/2001/XMLSchema#string

Ianko D Iankov

http://www.w3.org/2001/XMLSchema#string

John C Morris

http://www.w3.org/2001/XMLSchema#string

Michael Koutsilieris

http://www.w3.org/2001/XMLSchema#string

Pavlos Msaouel

http://www.w3.org/2001/XMLSchema#string

Veronika von Messling

http://www.w3.org/2001/XMLSchema#string

P2860

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

Cancer statistics, 2008

SLAM (CDw150) is a cellular receptor for measles virus

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Immune evasion of tumor cells using membrane-bound complement regulatory proteins.

Measles virus spread and pathogenesis in genetically modified mice.

In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein.

Complement resistance of tumor cells: basal and induced mechanisms.

P304

82-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.20857

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Russell

Roberto Cattaneo

Evanthia Galanis

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23440735

http://www.w3.org/2001/XMLSchema#string

P698

18973133

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2737678

http://www.w3.org/2001/XMLSchema#string